May 29 (Reuters) - Catalent said on Wednesday its stockholders have voted to approve its deal with Novo Holdings, the parent company of Novo Nordisk.

In February, Novo Holdings had agreed to buy Catalent for $16.5 billion. (Reporting by Sriparna Roy in Bengaluru; Editing by Vijay Kishore)